Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective
1
x
$
30.00
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
1
x
$
30.00
Table of Contents, Vol 47, No. 2, 2017
1
x
$
0.00
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
1
x
$
30.00
Antipsychotic-Induced Laryngeal Dystonia
2
x
$
30.00
Myotoxicity Induced by Antiepileptic Drugs: Could be a Rare but Serious Adverse Event?
1
x
$
30.00
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
1
x
$
30.00
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
1
x
$
30.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
Ultrasonically Determined Thyroid Volume in Individuals with Bipolar Disorder on Lithium Prophylaxis Compared with Healthy Controls
1
x
$
30.00
Dose-Dependent Urinary Incontinence with Sertraline Use in Obsessive-Compulsive Disorder
1
x
$
30.00
View Cart
Checkout
Home
dosage-regimen-design
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$
30.00
Add to cart
Details
Page load link
Go to Top
